Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq, in what is being seen as a test of the appetite among investors for earlier-stage drug developers. The ...
For the first time, children in the US as young as two with the blood disorders sickle cell disease and beta thalassaemia are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results